IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v2y2020i3id40321.html

Orbital Leiomyosarcoma After Bilateral Retinoblastoma Treated With Chemotherapy And Radiotherapy

Author

Listed:
  • Aoife Smyth

    (Mater Misericordiae University Hospital, Ireland)

  • Elizabeth M. McElnea

    (Royal Victorian Eye and Ear Hospital, Australia)

  • Penelope McKelvie

    (St Vincents Hospital, Australia)

  • Alan McNab

    (University of Melbourne, Australia)

Abstract

A 23-year old man presented with a swelling medially in his left orbit. He had had bilateral retinoblastoma as an infant and was treated with bilateral enucleation, chemotherapy and radiotherapy. Histological examination confirmed the lesion to be leiomyosarcoma. A genetic defect in the RB1 tumour suppressor gene underlies the development of hereditary retinoblastoma and renders patients at substantially increased risk of developing subsequent non-ocular malignancies including soft tissue sarcomas. This risk is enhanced by radiotherapy particularly if administered before the age of one year. Awareness, by both patients and healthcare professionals, of this risk of secondary malignancy, is extremely important. Identification and aggressive investigation of new symptoms and signs may allow for the earlier detection of secondary malignancy which may, in turn, improve outcomes.

Suggested Citation

  • Aoife Smyth & Elizabeth M. McElnea & Penelope McKelvie & Alan McNab, 2020. "Orbital Leiomyosarcoma After Bilateral Retinoblastoma Treated With Chemotherapy And Radiotherapy," European Journal of Medical and Health Sciences, European Open Science, vol. 2(3), May.
    • Handle: RePEc:epw:ejmed0:v:2:y:2020:i:3:id:40321
    DOI: 10.24018/ejmed.2020.2.3.321
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/40321
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/40321/8903
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2020.2.3.321?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:2:y:2020:i:3:id:40321. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.